Erratum to: Trends in Lipid-Lowering Prescriptions: Increasing Use of Guideline-Concordant Pharmacotherapies, U.S., 2017-2022. Sekkarie A, Park S, Therrien NL, et al. Am J Prev Med. 2023;64(4):561-566
- PMID: 37256237
- DOI: 10.1016/j.amepre.2023.05.017
Erratum to: Trends in Lipid-Lowering Prescriptions: Increasing Use of Guideline-Concordant Pharmacotherapies, U.S., 2017-2022. Sekkarie A, Park S, Therrien NL, et al. Am J Prev Med. 2023;64(4):561-566
Erratum for
-
Trends in Lipid-Lowering Prescriptions: Increasing Use of Guideline-Concordant Pharmacotherapies, U.S., 2017‒2022.Am J Prev Med. 2023 Apr;64(4):561-566. doi: 10.1016/j.amepre.2022.10.010. Epub 2022 Dec 1. Am J Prev Med. 2023. PMID: 36464556 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources